Gregory C. Howard

939 total citations
14 papers, 468 citations indexed

About

Gregory C. Howard is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Gregory C. Howard has authored 14 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Genetics. Recurrent topics in Gregory C. Howard's work include Genomics and Chromatin Dynamics (6 papers), Cancer-related gene regulation (5 papers) and Ubiquitin and proteasome pathways (4 papers). Gregory C. Howard is often cited by papers focused on Genomics and Chromatin Dynamics (6 papers), Cancer-related gene regulation (5 papers) and Ubiquitin and proteasome pathways (4 papers). Gregory C. Howard collaborates with scholars based in United States, Switzerland and Germany. Gregory C. Howard's co-authors include William P. Tansey, Shelly L. Lorey, Stephen W. Fesik, April M. Weissmiller, Lance R. Thomas, Christine M. Eischen, Audra F. Bryan, Brian C. Grieb, Edward T. Olejniczak and Bethany M. Alicie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Gregory C. Howard

14 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory C. Howard United States 9 402 91 53 40 37 14 468
Manuela Hugle Germany 11 263 0.7× 107 1.2× 41 0.8× 26 0.7× 25 0.7× 14 365
Pravina Fernandez United States 4 514 1.3× 79 0.9× 43 0.8× 21 0.5× 52 1.4× 11 572
Thomas S.K. Gilbert United States 12 265 0.7× 104 1.1× 54 1.0× 17 0.4× 30 0.8× 16 373
Aiqin Sun China 12 364 0.9× 125 1.4× 67 1.3× 27 0.7× 56 1.5× 29 499
Loren Lasko United States 11 288 0.7× 196 2.2× 25 0.5× 22 0.6× 67 1.8× 13 421
Jihui Qiu United States 13 393 1.0× 73 0.8× 69 1.3× 27 0.7× 34 0.9× 16 513
Lars A.T. Meijer Netherlands 8 310 0.8× 91 1.0× 26 0.5× 16 0.4× 30 0.8× 8 362
Gloria Milani Italy 11 251 0.6× 69 0.8× 57 1.1× 22 0.6× 70 1.9× 16 420
Pauline J. van der Watt South Africa 14 546 1.4× 144 1.6× 61 1.2× 31 0.8× 23 0.6× 23 682
George Yam United States 4 289 0.7× 99 1.1× 31 0.6× 23 0.6× 140 3.8× 5 405

Countries citing papers authored by Gregory C. Howard

Since Specialization
Citations

This map shows the geographic impact of Gregory C. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory C. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory C. Howard more than expected).

Fields of papers citing papers by Gregory C. Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory C. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory C. Howard. The network helps show where Gregory C. Howard may publish in the future.

Co-authorship network of co-authors of Gregory C. Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory C. Howard. A scholar is included among the top collaborators of Gregory C. Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory C. Howard. Gregory C. Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Howard, Gregory C. & William P. Tansey. (2025). Ribosome-directed cancer therapies: the tip of the iceberg?. Trends in Pharmacological Sciences. 46(4). 303–310. 2 indexed citations
2.
Meyer, Christian T., Jing Wang, Brian C. Grieb, et al.. (2024). Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies. Proceedings of the National Academy of Sciences. 121(35). e2408889121–e2408889121. 4 indexed citations
3.
Howard, Gregory C., Jing Wang, Kristie L. Rose, et al.. (2023). Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition. eLife. 12. 9 indexed citations
4.
Wang, Jing, Lance R. Thomas, Brittany K. Matlock, et al.. (2022). WIN site inhibition disrupts a subset of WDR5 function. Scientific Reports. 12(1). 1848–1848. 16 indexed citations
5.
Chowdhury, Somenath, Kenneth M. Meyers, Jianhua Tian, et al.. (2022). Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models. Proceedings of the National Academy of Sciences. 120(1). e2211297120–e2211297120. 17 indexed citations
6.
Wang, Jing, Brian C. Grieb, Chih–Yuan Hsu, et al.. (2022). Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells. NAR Cancer. 4(1). zcac007–zcac007. 13 indexed citations
7.
Wang, Jing, Clare M. Adams, Gregory C. Howard, et al.. (2021). MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1. eLife. 10. 58 indexed citations
8.
Howard, Gregory C., et al.. (2020). AtPIG-S, a predicted Glycosylphosphatidylinositol Transamidase subunit, is critical for pollen tube growth in Arabidopsis. BMC Plant Biology. 20(1). 380–380. 8 indexed citations
9.
Bryan, Audra F., Jing Wang, Gregory C. Howard, et al.. (2020). WDR5 is a conserved regulator of protein synthesis gene expression. Nucleic Acids Research. 48(6). 2924–2941. 50 indexed citations
10.
Weissmiller, April M., Jing Wang, Shelly L. Lorey, et al.. (2019). Inhibition of MYC by the SMARCB1 tumor suppressor. Nature Communications. 10(1). 54 indexed citations
11.
Howard, Gregory C. & William P. Tansey. (2016). Interaction of Gcn4 with target gene chromatin is modulated by proteasome function. Molecular Biology of the Cell. 27(17). 2735–2741. 4 indexed citations
12.
Thomas, Lance R., Qingguo Wang, Brian C. Grieb, et al.. (2015). Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC. Molecular Cell. 58(3). 440–452. 215 indexed citations
13.
Hérissant, Lucas, Wojciech Pokrzywa, Fuqiang Geng, et al.. (2014). The ubiquitin-selective chaperone Cdc48/p97 associates with Ubx3 to modulate monoubiquitylation of histone H2B. Nucleic Acids Research. 42(17). 10975–10986. 12 indexed citations
14.
Ganguly, Sourik S., et al.. (2008). Characterization of osteoblastic properties of 7F2 and UMR-106 cultures after acclimation to reduced levels of fetal bovine serum. Canadian Journal of Physiology and Pharmacology. 86(7). 403–415. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026